查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917860

虚拟实境暴露疗法市场—2026-2031年预测

Virtual Reality Exposure Therapy Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

虚拟实境暴露疗法 (VRET) 市场预计将从 2025 年的 863,514,000 美元成长到 2031 年的 4,853,003,000 美元，复合年增长率为 33.34%。

虚拟实境暴露疗法 (VRET) 市场由专门的软体、身临其境型虚拟环境和相关硬体组成，用于提供治疗焦虑症、恐惧症和创伤后压力症候群 (PTSD) 的心理疗法。 VRET 利用身临其境型虚拟实境技术，旨在让患者在受过训练的临床医生的指导下，在可控、安全且可重复的环境中接触恐惧刺激。此疗法以数位媒介的形式体现了实证暴露疗法的原则，而暴露疗法是治疗许多焦虑症的黄金标准。具体而言，它创建了越来越逼真的焦虑诱发情境模拟，这些情境在现实生活中可能难以、不切实际或不道德地重现（例如，飞行恐惧症、PTSD 的战斗场景）。

市场扩张的根本驱动力在于临床上对更有效、更容易取得且扩充性的焦虑和创伤相关障碍治疗方法的迫切需求。关键驱动因素是这些疾病的高发生率以及传统治疗方法的限制。传统的暴露疗法在实施过程中可能面临诸多挑战，例如依赖患者想像力的“想像暴露疗法”，以及成本高昂且难以控制的“动手暴露疗法”。虚拟实境暴露疗法（VRET）透过提供标准化、按需、安全的暴露环境克服了这些障碍，所有操作均由临床医生管理，从而提高了治疗的一致性、效率和患者的耐受性。

同时，消费级虚拟实境技术的快速发展也是一股强大的推动力。头显显示解析度、视野范围、无线功能和运动追踪技术的提升，显着增强了虚拟环境的真实感和沈浸感。这种沉浸感的增强对于激活患者的恐惧机制、提升治疗效果至关重要。此外，虚拟实境硬体成本的下降和品质的提高，降低了诊所和治疗师的进入门槛，使虚拟实境恐惧疗法（VRET）从一种小众研究工具转变为一种可行的临床实践。

影响虚拟实境暴露疗法（VRET）普及的关键趋势在于其高度个人化和针对性治疗能力。现代VRET平台提供丰富的客製化环境库（例如，高度、社交场合、机场），并允许在治疗过程中即时调整特定参数（例如，人群密度、天气、虚拟教练的支援）。这使得治疗师能够根据患者的个别恐惧等级和进展进展精准地客製化暴露疗法，而传统方法很难做到这一点。这种精准性提高了治疗效果和患者的参与度。

从地理位置来看，北美是虚拟实境治疗（VRET）领域最发达的市场，其特点是拥有强大的VRET学术研究基础、高度集中的技术开发人员、不断扩展的报销途径以及日益受到心理健康专业人士的认可。该地区的领先地位得益于其医疗保健生态系统，该系统促进了治疗方式的技术创新。

竞争格局包括专注于数位疗法的公司、学术机构以及虚拟实境内容开发商与临床心理学家之间的合作计画。竞争的焦点在于虚拟环境的临床相关性和真实性、治疗师控制介面的精细程度、​​内建评估和进度追踪工具的稳健性，以及与临床工作流程的整合能力。成功与否取决于透过已发表的研究证明其具有显着的临床疗效，以及获得精神病学和心理学领域关键人物的认可。

儘管市场前景广阔，但推广应用仍面临诸多障碍。最大的挑战在于如何将其融入标准临床实践，这需要说服接受传统培训的治疗师采用新技术，提供充分的培训，并证明其工作流程相比现有方法具有明显的优势。报销机制仍然复杂多变，虽然取得了一些进展，但将虚拟实境能量疗法（VRET）作为一项独立服务，并拥有明确的CPT代码，尚未得到广泛报销。此外，儘管硬体成本下降，但诊所的总投入（耳机、软体授权、专用场地）仍然是一个障碍。

总之，虚拟实境暴露疗法（VRET）市场代表着临床心理学与身临其境型技术的强强联合，引领着暴露疗法实施方式的模式转移。其成长得益于结构性因素：焦虑症的高发生率和虚拟实境技术的成熟。对于行业专家而言，策略重点应放在以下三点：产生更可靠的纵向临床数据，以巩固循证指南；开发承包解决方案，最大限度地减少临床医生的技术负担；以及积极与支付方合作，建立永续的报销模式。未来在于能够动态回应患者生理变化（透过生物回馈疗法）的自适应、人工智慧增强型虚拟实境环境，以及支援远端指导的VRET远距治疗模式。 VRET的成功将取决于其能否从一种新型干预手段转变为一种主流的、必不可少的治疗工具，并因其能够以可扩展且患者可接受的方式提供精准、循证的治疗而获得认可。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：分析市场驱动因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在动态环境中製定策略决策，并开拓新的业务管道和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 虚拟实境体验市场（按组件划分）

  • 介绍
  • 硬体
  • 软体

第六章 虚拟实境曝光市场（依应用划分）

  • 介绍
  • 创伤后压力症候群（PTSD）
  • 恐惧症和惊恐障碍
  • 强迫症（OCD）
  • 焦虑症
  • 其他的

7. 以最终用户分類的虚拟实境体验市场

  • 介绍
  • 医院
  • 精神病诊所
  • 其他的

8. 各地区的虚拟实境体验市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Virtually Better, Inc.
  • Limbx（Big Health）
  • XRHealth
  • Oxford Medical Simulation Ltd.
  • AppliedVR, Inc.
  • Virtual Reality Medical Center（VRMC）
  • MindMaze
  • Firsthand Technology Inc.
  • oVRcome
  • Coastal Wellness & Life Coaching Center

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615860

Virtual Reality Exposure Therapy Market is projected to expand at a 33.34% CAGR, attaining USD 4853.003 million in 2031 from USD 863.514 million in 2025.

The virtual reality exposure therapy (VRET) market comprises specialized software, immersive virtual environments, and associated hardware used to deliver a form of psychotherapy that treats anxiety disorders, phobias, and PTSD. VRET leverages immersive virtual reality technology to expose patients to feared stimuli in a controlled, safe, and repeatable setting, guided by a trained clinician. It operationalizes the evidence-based principles of exposure therapy-the gold standard for many anxiety conditions-by using a digital medium to create graduated, realistic simulations of anxiety-provoking situations that may be difficult, impractical, or unethical to replicate in real life (e.g., fear of flying, combat scenarios for PTSD).

Market expansion is fundamentally driven by the compelling clinical need for more effective, accessible, and scalable treatments for anxiety and trauma-related disorders. A primary catalyst is the significant prevalence of these conditions and the limitations of traditional therapy. Conventional exposure therapy can be logistically challenging, reliant on patient imagination ("imaginal exposure"), or involve costly and uncontrollable real-world excursions ("in vivo exposure"). VRET overcomes these barriers by providing a standardized, on-demand, and safe environment for exposure that is entirely under the clinician's control, making the therapy more consistent, efficient, and tolerable for many patients.

Concurrently, rapid advancements in consumer-grade VR technology are a powerful enabling driver. Improvements in headset display resolution, field of view, wireless capability, and motion tracking have dramatically increased the realism and sense of "presence" within the virtual environment. This enhanced immersion is critical for activating the patient's fear structure and making the therapeutic experience effective. Furthermore, the falling cost and rising quality of VR hardware have lowered the barrier to entry for clinics and therapists, moving VRET from a niche research tool toward a viable clinical modality.

A significant trend shaping adoption is the ability to provide highly personalized and targeted treatment. Modern VRET platforms offer libraries of customizable environments (e.g., heights, social gatherings, airports) and the ability to modify specific parameters (crowd density, weather, virtual coach support) in real-time during a session. This allows therapists to tailor the exposure precisely to a patient's individual fear hierarchy and progress, something that is far more difficult to achieve with traditional methods. This precision enhances treatment efficacy and patient engagement.

Geographically, North America represents the most advanced market, characterized by a strong academic research foundation in VRET, a high concentration of technology developers, growing reimbursement pathways, and greater awareness among mental health practitioners. The region's leadership is supported by a healthcare ecosystem that often incentivizes technological innovation in treatment delivery.

The competitive landscape includes specialized digital therapeutics companies, academic spin-offs, and partnerships between VR content developers and clinical psychologists. Competition centers on the clinical validity and realism of the virtual environments, the sophistication of the therapist's control interface, the robustness of built-in assessment and progress-tracking tools, and the ability to integrate with clinical workflows. Success hinges on demonstrating strong clinical outcomes through published research and securing validation from key opinion leaders in psychiatry and psychology.

Despite its promise, the market faces significant adoption barriers. The foremost challenge is integration into standard clinical practice. This requires convincing traditionally trained therapists to adopt a new technology, providing them with adequate training, and demonstrating a clear workflow benefit over established methods. Reimbursement remains a complex and evolving landscape; while some progress is being made, clear CPT codes and widespread insurance coverage for VRET as a discrete service are not yet universal. Additionally, while hardware costs have fallen, the total investment for a clinic (headsets, software licenses, dedicated space) can still be a hurdle.

In conclusion, the VRET market represents a powerful convergence of clinical psychology and immersive technology, offering a paradigm shift in the delivery of exposure-based treatments. Its growth is structurally supported by the high burden of anxiety disorders and the technological maturation of VR. For industry experts, strategic focus must center on generating even more robust longitudinal clinical data to solidify evidence-based guidelines, developing turnkey solutions that minimize the technical burden on clinicians, and actively engaging with payers to establish sustainable reimbursement models. The future lies in adaptive, AI-enhanced VR environments that respond dynamically to patient physiology (via biofeedback) and in teletherapy models that allow remote delivery of guided VRET. Success will be defined by VRET's transition from a novel intervention to a mainstream, indispensable tool in the therapist's arsenal, recognized for its unique ability to deliver precise, evidence-based care in a scalable and patient-acceptable format.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Virtual Reality Exposure Market Segmentation

  • By Component
  • Hardware
  • Software
  • By Application
  • Post Traumatic Stress Disorder (PTSD)
  • Phobias & Panic Disorder
  • Obsessive Compulsive Disorder (OCD)
  • Anxiety Disorder
  • Others
  • By End-User
  • Hospitals
  • Mental Health Clinics
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VIRTUAL REALITY EXPOSURE MARKET BY COMPONENT

  • 5.1. Introduction
  • 5.2. Hardware
  • 5.3. Softwre

6. VIRTUAL REALITY EXPOSURE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Post Traumatic Stress Disorder (PTSD)
  • 6.3. Phobias & Panic Disorder
  • 6.4. Obsessive Compulsive Disorder (OCD)
  • 6.5. Anxiety Disorder
  • 6.6. Others

7. VIRTUAL REALITY EXPOSURE MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Mental Health Clinics
  • 7.4. Others

8. VIRTUAL REALITY EXPOSURE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Virtually Better, Inc.
  • 10.2. Limbx (Big Health)
  • 10.3. XRHealth
  • 10.4. Oxford Medical Simulation Ltd.
  • 10.5. AppliedVR, Inc.
  • 10.6. Virtual Reality Medical Center (VRMC)
  • 10.7. MindMaze
  • 10.8. Firsthand Technology Inc.
  • 10.9. oVRcome
  • 10.10. Coastal Wellness & Life Coaching Center

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations